Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1971;44:612-616

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DAS, S. K.
Right arrow Articles by CASSIDY, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAS, S. K.
Right arrow Articles by CASSIDY, J. T.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy

(Circulation. 1971;44:612.)
© 1971 American Heart Association, Inc.


Immunoglobulin Binding in Cardiomyopathic Hearts

SUNIL K. DAS M.D.1; JEFFERY P. CALLEN B.A.1; VERNON N. DODSON M.D.1; JAMES T. CASSIDY M.D.1

1 From the Department of Internal Medicine and the Heart Station, University of Michigan Medical School, Ann Arbor, Michigan 48104.

Bound gamma globulin was demonstrated by the direct immunofluorescent technique in heart tissue from three patients with severe congestive cardiomyopathy. In two of these patients complement (beta1C) was also bound to the heart muscle. Heart tissue from one of six patients who died of myocardial infarction showed a trace of bound gamma globulin, but no bound complement. During life, the heart in advanced cardiomyopathy may preferentially fix heart-reactive immunoglobulins to specific sarcolemmal and subsarcolemmal antigens, and antiheart antibody may not be detectable in the serum.


Key Words: Cardiomyopathy • Gamma globulin • Immunofluorescence • Complement

Submitted on February 24, 1971
Accepted on June 7, 1971